Acquired haemophilia A after alemtuzumab treatment of multiple sclerosis
Br J Haematol
.
2020 Jul;190(1):13.
doi: 10.1111/bjh.16644.
Epub 2020 Apr 16.
Authors
Huguette S Brink
1
,
Wibe Moll
2
,
Yorick Sandberg
1
Affiliations
1
Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands.
2
Department of Neurology, Maasstad Hospital, Rotterdam, The Netherlands.
PMID:
32301108
DOI:
10.1111/bjh.16644
No abstract available
Publication types
Case Reports
MeSH terms
Adult
Alemtuzumab / adverse effects*
Hemophilia A / chemically induced*
Humans
Male
Multiple Sclerosis / complications*
Multiple Sclerosis / drug therapy*
Substances
Alemtuzumab